Educational Objective: To review the risks and benefits of androgen deprivation therapy for prostate cancer.

CME HOME | JAMA & ARCHIVES HOME | MY CME | SUBSCRIBE | E-MAIL ALERTS | HELP CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP   © 2008 American Medical Association Journals Continuing Medical Education Program. All Rights Reserved.